STAT3 is involved in phosphatidic acid-induced Bcl-2 expression in HeLa cells

Experimental and Molecular Medicine

Volumn 41, Issue 2, 2009, Pages 94-101

  Choi, Hye Jin ^a   Jung, Han Lee ^a   Park, Shin Young ^a   Ju, Hwan Cho ^a   Han, Joong Soo ^a  

^a Hanyang University   (South Korea)

Author keywords

Extracellular signal regulated MAP kinases; Phosphatidic acids; Phospholipases A2; Proto oncogene proteins c bcl 2; Stat3 transcription factor

Indexed keywords

1,2 DIPALMITORYL SN GLYCERO 3 PHOSPHATE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ARACHIDONIC ACID; LYSOPHOSPHATIDIC ACID; MEPACRINE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATE; PHOSPHATIDATE PHOSPHATASE; PHOSPHATIDIC ACID; PROPRANOLOL DERIVATIVE; PROTEIN BCL 2; SMALL INTERFERING RNA; STAT3 PROTEIN; UNCLASSIFIED DRUG; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROPRANOLOL;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION; GENE EXPRESSION REGULATION; GENETICS; HELA CELL; METABOLISM;

ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PHOSPHATIDIC ACIDS; PROPRANOLOL; PROTO-ONCOGENE PROTEINS C-BCL-2; QUINACRINE; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR;

EID: 63849342104     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.3858/emm.2009.41.2.012     Document Type: Article

References (40)

1. Adams JM, Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci 2001;26:61-66 (Pubitemid 32124712)
2. Alas S, Bonavida B. Rituximab inactivates signal transducer and activation of transcription 3 (STAT3) activity in B-non- Hodgkin's lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs. Cancer Res 2001;61:5137-5144 (Pubitemid 32681546)
3. Boucher MJ, Morisset J, Vachon PH, Reed JC, Laine J, Rivard N. MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X (L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J Cell Biochem 2000;79:355-369
4. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE Jr. Stat3 as an oncogene. Cell 1999;98:295-303 (Pubitemid 29380565)
5. Cho JH, Hong SK, Kim EY, Park SY, Park CH, Kim JM, Kwon OJ, Kwon SJ, Lee KS, Han JS. Overexpression of phospholipase D suppresses taxotere-induced cell death in stomach cancer cells. Biochim Biophys Acta 2008;1783: 912-923
6. Choi YK, Kim TK, Kim CJ, Lee JS, Oh SY, Joo HS, Foster DN, Hong KC, You S, Kim H. Activation of the intrinsic mitochondrial apoptotic pathway in swine influenza virusmediated cell death. Exp Mol Med 2006;38:11-17 (Pubitemid 43352429)
7. Chung J, Uchida E, Grammer TC, Blenis J. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol 1997;17:6508-6516 (Pubitemid 27451197)
8. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-1421 (Pubitemid 24217131)
9. Erickson RW, Langel-Peveri P, Traynor-Kaplan AE, Heyworth PG, Curnutte JT. Activation of human neutrophil NADPH oxidase by phosphatidic acid or diacylglycerol in a cell-free system. Activity of diacylglycerol is dependent on its conversion to phosphatidic acid. J Biol Chem 1999;274: 22243-22250
10. Froesch BA, Aime-Sempe C, Leber B, Andrews D, Reed JC. Inhibition of p53 transcriptional activity by Bcl-2 requires its membrane-anchoring domain. J Biol Chem 1999;274: 6469-6475 (Pubitemid 29111062)
11. Ghosh S, Strum JC, Sciorra VA, Daniel L, Bell RM. Raf-1 kinase possesses distinct binding domains for phosphatidylserine and phosphatidic acid. Phosphatidic acid regulates the translocation of Raf-1 in 12-O- tetradecanoylphorbol- 13-acetate-stimulated Madin-Darby canine kidney cells. J Biol Chem 1996;271:8472-8480
12. Gotoh A, Takahira H, Mantel C, Litz-Jackson S, Boswell HS, Broxmeyer HE. Steel factor induces serine phosphorylation of Stat3 in human growth factor-dependent myeloid cell lines. Blood 1996;88:138-145 (Pubitemid 26230681)
13. Heim MH. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus. J Recept Signal Transduct Res 1999;19:75-120 (Pubitemid 29152176)
14. Herrmann JL, Menter DG, Beham A, von Eschenbach A, McDonnell TJ. Regulation of lipid signaling pathways for cell survival and apoptosis by bcl-2 in prostate carcinoma cells. Exp Cell Res 1997;234:442-451 (Pubitemid 27335188)
15. Huang DC, Strasser A. BH3-Only proteins-essential initiators of apoptotic cell death. Cell 2000;103:839-842
16. Ihle JN. Cytokine receptor signaling. Nature 1995;377:591-594
17. Kim HJ, Yang SJ, Kim YS, Kim TU. Cobalt chloride-induced apoptosis and extracellular signal-regulated protein kinase activation in human cervical cancer HeLa cells. J Biochem Mol Biol 2003;36:468-474 (Pubitemid 37346906)
18. Knauss TC, Jaffer FE, Abboud HE. Phosphatidic acid modulates DNA synthesis, phospholipase C, and plateletderived growth factor mRNAs in cultured mesangial cells. Role of protein kinase C. J Biol Chem 1990;265:14457-14463
19. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992;80:879-886
20. Lee DY, Lee MW, Lee HJ, Noh YH, Park SC, Lee MY, Kim KY, Lee WB, Kim SS. ERK1/2 activation attenuates TRAILinduced apoptosis through the regulation of mitochondriadependent pathway. Toxicol In Vitro 2006;20:816-823 (Pubitemid 43914354)
21. Lim CP, Cao X. Serine phosphorylation and negative regulation of Stat3 by JNK. J Biol Chem 1999;274:31055-31061 (Pubitemid 129576860)
22. Lu PJ, Lu QL, Rughetti A, Taylor-Papadimitriou J. Bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not tumorigenesis of human mammary epithelial cells. J Cell Biol 1995;129:1363-1378
23. Miyashita T, Kitada S, Krajewski S, Horne WA, Delia D, Reed JC. Overexpression of the Bcl-2 protein increases the half-life of p21Bax. J Biol Chem 1995;270:26049-26052
24. Moolenaar WH, Kruiger W, Tilly BC, Verlaan I, Bierman AJ, de Laat SW. Growth factor-like action of phosphatidic acid. Nature 1986;323:171-173 (Pubitemid 16024967)
25. Newmeyer DD, Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell 2003;112:481-490 (Pubitemid 36263081)
26. Ng J, Cantrell D. STAT3 is a serine kinase target in T lymphocytes. Interleukin 2 and T cell antigen receptor signals converge upon serine 727. J Biol Chem 1997;272:24542-24549
27. Oh KJ, Lee SC, Choi HJ, Oh DY, Kim SC, Min DS, Kim JM, Lee KS, Han JS. Role of phospholipase D2 in anti-apoptotic signaling through increased expressions of Bcl-2 and Bcl-xL. J Cell Biochem 2007;101:1409-1422 (Pubitemid 47242772)
28. O'Reilly LA, Harris AW, Strasser A. Bcl-2 transgene expression promotes survival and reduces proliferation of CD3-CD4-CD8- T cell progenitors. Int Immunol 1997;9:1291-1301
29. Perry DK, Stevens VL, Widlanski TS, Lambeth JD. A novel ecto-phosphatidic acid phosphohydrolase activity mediates activation of neutrophil superoxide generation by exogenous phosphatidic acid. J Biol Chem 1993;268:25302-25310 (Pubitemid 23358129)
30. Rahaman SO, Harbor PC, Chernova O, Barnett GH, Vogelbaum MA, Haque SJ. Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene 2002;21:8404-8413 (Pubitemid 36054883)
31. Ricca A, Biroccio A, Del Bufalo D, Mackay AR, Santoni A, Cippitelli M. Bcl-2 over-expression enhances NF-kappaB activity and induces mmp-9 transcription in human MCF7 (ADR) breast-cancer cells. Int J Cancer 2000;86:188-196 (Pubitemid 30180813)
32. Siegmann DW. Stimulation of quiescent 3T3 cells by phosphatidic acid-containing liposomes. Biochom Biophys Res Commun 1987;145:228-233 (Pubitemid 17088428)
33. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985;228:1440-1443 (Pubitemid 15041322)
34. Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 2003;195:158-167 (Pubitemid 36384290)
35. Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M, Frank DA, Holzman LB, Wu J, Sebti S, Jove R. Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol Cell Biol 1999;19:7519-7528 (Pubitemid 29493415)
36. Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335:440-442 (Pubitemid 18234863)
37. Wen Z, Zhong Z, Darnell JE Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 1995;82:241-250
38. Yokogami K, Wakisaka S, Avruch J, Reeves SA. Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr Biol 2000;10:47-50 (Pubitemid 30057415)
39. Yon C, Lee MH, Oh DY, Kim DS, Lee KS, Han JS. Advanced lipid extraction method for the determination of the phospholipase D activity. Arch Pharm Res 2003;26:478-481
40. Zushi S, Shinomura Y, Kiyohara T, Miyazaki Y, Kondo S, Sugimachi M, Higashimoto Y, Kanayama S, Matsuzawa Y. STAT3 mediates the survival signal in oncogenic rastransfected intestinal epithelial cells. Int J Cancer 1998;78: 326-330 (Pubitemid 28445370)